共 258 条
[1]
Gilks CB(2009)Ovarian carcinoma pathology and genetics: recent advances Hum Pathol 40 1213-23
[2]
Prat J(2013)Clinical trials of palliative chemotherapy in platinum-resistant or -refractory ovarian cancer: time to think differently? J Clin Oncol 31 2362-6
[3]
Friedlander ML(1997)Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines Cancer Res 57 850-6
[4]
Stockler MR(1994)Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells Cancer Res 54 5911-13
[5]
Butow P(2012)Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways J Oncol 2012 737981-92
[6]
King MT(2008)Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel Br J Cancer 99 1103-26
[7]
McAlpine J(2007)A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy Clin Cancer Res 13 6984-94
[8]
Tinker A(2004)A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817-16
[9]
Ledermann JA(2010)A breast cancer prognostic signature predicts clinical outcomes in multiple tumor types Oncol Rep 24 489-2009
[10]
Johnson SW(2010)A population-based gene signature is predictive of breast cancer survival and chemoresponse Int J Oncol 36 607-6